198 related articles for article (PubMed ID: 27038873)
1. Hypopituitarism patterns among adult males with prolactinomas.
Peng J; Qiu M; Qi S; Li D; Peng Y
Clin Neurol Neurosurg; 2016 May; 144():112-8. PubMed ID: 27038873
[TBL] [Abstract][Full Text] [Related]
2. Influence of age on the clinical presentation of prolactinomas in male patients.
Delgrange E; Maiter D; Donckier J; Tourniaire J
Gerontology; 1999; 45(3):160-4. PubMed ID: 10202261
[TBL] [Abstract][Full Text] [Related]
3. Hypopituitarism patterns and prevalence among men with macroprolactinomas.
Tirosh A; Benbassat C; Lifshitz A; Shimon I
Pituitary; 2015 Feb; 18(1):108-15. PubMed ID: 24700366
[TBL] [Abstract][Full Text] [Related]
4. Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas.
Arafah BM
J Clin Endocrinol Metab; 1986 Jun; 62(6):1173-9. PubMed ID: 3009521
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of anaemia associated with prolactin-secreting pituitary tumours in men.
Iglesias P; Castro JC; Díez JJ
Int J Clin Pract; 2011 Jun; 65(6):669-73. PubMed ID: 21564439
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of extensive spherical amyloid deposits in a prolactin-secreting pituitary macroadenoma: a radiologic-pathologic correlation.
Levine SN; Ishaq S; Nanda A; Wilson JD; Gonzalez-Toledo E
Ann Diagn Pathol; 2013 Aug; 17(4):361-6. PubMed ID: 23602507
[TBL] [Abstract][Full Text] [Related]
7. How does pregnancy affect the patients with pituitary adenomas: a study on 113 pregnancies from Turkey.
Karaca Z; Yarman S; Ozbas I; Kadioglu P; Akturk M; Kilicli F; Dokmetas HS; Colak R; Atmaca H; Canturk Z; Altuntas Y; Ozbey N; Hatipoglu N; Tanriverdi F; Unluhizarci K; Kelestimur F
J Endocrinol Invest; 2018 Jan; 41(1):129-141. PubMed ID: 28634705
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging in the management of prolactinomas; a review of the evidence.
Varlamov EV; Hinojosa-Amaya JM; Fleseriu M
Pituitary; 2020 Feb; 23(1):16-26. PubMed ID: 31659622
[TBL] [Abstract][Full Text] [Related]
9. Relationship of each anterior pituitary hormone deficiency to the size of non-functioning pituitary adenoma in the hospitalized patients.
Mukai K; Kitamura T; Tamada D; Murata M; Otsuki M; Shimomura I
Endocr J; 2016 Nov; 63(11):965-976. PubMed ID: 27534814
[TBL] [Abstract][Full Text] [Related]
10. Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis.
Jahangiri A; Wagner JR; Han SW; Tran MT; Miller LM; Chen R; Tom MW; Ostling LR; Kunwar S; Blevins L; Aghi MK
J Neurosurg; 2016 Mar; 124(3):589-95. PubMed ID: 26252454
[TBL] [Abstract][Full Text] [Related]
11. Intensity of prolactinoma on T2-weighted magnetic resonance imaging: towards another gender difference.
Kreutz J; Vroonen L; Cattin F; Petrossians P; Thiry A; Rostomyan L; Tshibanda L; Beckers A; Bonneville JF
Neuroradiology; 2015 Jul; 57(7):679-84. PubMed ID: 25845810
[TBL] [Abstract][Full Text] [Related]
12. Obesity and hypercholesterolemia in patients with prolactinomas: Could DHEA-S and growth hormone be the missing link?
Perić B; Kruljac I; Šundalić S; Pećina HI; Jović A; Štefanović M; Butorac D; Vrkljan M
Endocr Res; 2016 Aug; 41(3):200-6. PubMed ID: 26864960
[TBL] [Abstract][Full Text] [Related]
13. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
14. Proportion and predictors of Hypogonadism Recovery in Men with Macroprolactinomas treated with dopamine agonists.
Al Dahmani KM; Almalki MH; Ekhzaimy A; Aziz F; Bashier A; Mahzari MM; Beshyah SA
Pituitary; 2022 Aug; 25(4):658-666. PubMed ID: 35793046
[TBL] [Abstract][Full Text] [Related]
15. Hyperprolactinemia and Hypopituitarism in Acromegaly and Effect of Pituitary Surgery: Long-Term Follow-up on 529 Patients.
Guo X; Zhang R; Zhang D; Wang Z; Gao L; Yao Y; Deng K; Bao X; Feng M; Xu Z; Yang Y; Lian W; Wang R; Ma W; Xing B
Front Endocrinol (Lausanne); 2021; 12():807054. PubMed ID: 35154007
[TBL] [Abstract][Full Text] [Related]
16. Temozolomide retreatment in a recurrent prolactin-secreting pituitary adenoma: Hormonal and radiographic response.
Strowd RE; Salvatori R; Laterra JJ
J Oncol Pharm Pract; 2016 Jun; 22(3):517-22. PubMed ID: 25616657
[TBL] [Abstract][Full Text] [Related]
17. [Computerized tomography of the pituitary gland in the diagnosis of prolactinoma: a concordance study].
Soriguer Escofet FJ; Rodríguez Navarro MP; Rodríguez San Pedro F; Sanz JM; Esteva de Antonio I; García Arnés JA; Escolar Castellón JL; Mazuecos F
Med Clin (Barc); 1991 Sep; 97(9):331-4. PubMed ID: 1961060
[TBL] [Abstract][Full Text] [Related]
18. Impaired growth hormone secretion in patients operated for pituitary adenomas.
Hoeck HC; Bang F; Laurberg P
Growth Regul; 1994 Jun; 4(2):63-7. PubMed ID: 7950904
[TBL] [Abstract][Full Text] [Related]
19. Radiological Growth Patterns of Prolactinomas and Nonfunctioning Adenomas.
Imran SA; Shankar J; Hebb ALO; Croul SE; Clarke DB
Can J Neurol Sci; 2017 Sep; 44(5):508-513. PubMed ID: 28669359
[TBL] [Abstract][Full Text] [Related]
20. Pituitary tumors. Current concepts in diagnosis and management.
Aron DC; Tyrrell JB; Wilson CB
West J Med; 1995 Apr; 162(4):340-52. PubMed ID: 7747500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
